A big thank you to all our donors and corporate partners who participated in the Fall 2012 Workplace Giving campaign. Your generous contributions continue to support Maryland's most trusted health charities!
Here are 5 reasons why your donation to Community Health Charities of Maryland and its 52 local member charities makes such a significant impact:
1. Did you know? 1,490,566 Marylanders are served annually by Community Health Charities of Maryland member health organizations.
2. More than half of Americans suffer from one or more chronic diseases.Chronic diseases account for 70% of all deaths in the U.S.
3. Consider this! On average, in a company with 100 employees:
25 have cardiovascular disease
12 have asthma
6 have diabetes
26 have high blood pressure
30 have high cholesterol
31 use alcohol excessively
44 suffer from stress
4. More than 50 million people provide care for a chronically ill, disabled, or aged family member or friend during any given year.
5. For the cost of...
$1 per two-week pay period, you can send a child with epilepsy to a morning of summer camp.
$10, you can provide diabetes risk tests to 500 individuals.
$200, you support 1 month of dialysis medication for a patient.
THANK YOU FOR YOUR SUPPORT!
CONGRATULATIONS TO OUR 2012 CORPORATE AWARD RECIPIENTS!
For people with life-threatening blood cancers like leukemia,
lymphoma or other diseases, a cure exists. Be The Match® connects patients with
their donor match for a life-saving marrow or umbilical cord blood transplant.
TAMPA, Fla. Alison Willing searches for hope for stroke patients. Her research uses umbilical cord blood to lessen stroke effects in rats. “Umbilical cord blood is considered by many to be medical waste after birth,” says Dr. Willing. Her research has shown that using cells from cord blood to treat strokes in rats lessens brain damage.
TAMPA, Fla. Alison Willing searches for hope for stroke patients. Her research uses umbilical cord blood to lessen stroke effects in rats. “Umbilical cord blood is considered by many to be medical waste after birth,” says Dr. Willing. Her research has shown that using cells from cord blood to treat strokes in rats lessens brain damage. The rats are able to function at almost normal levels following treatment. “With the support of the American Heart Association, we have answered critical questions about underlying stroke pathology and how cord blood cells induce recovery.”
Unlike current stroke treatments that need to be delivered within three hours of onset, Dr. Willing’s findings show cord blood cells work better when delivered later, up to 48 hours after onset. In addition, she found that cord blood cells decrease inflammation in the brain and the rest of the body that has been caused by stroke and this essentially rescues dying neurons in the brain. This opens up opportunities for new treatments that don’t target the brain. If Dr. Willing’s results can be translated into the clinic either as a cord blood or a novel pharmacologic treatment, it means that the majority of stroke patients could be treated, decreasing mortality and improving quality of life for survivors.